Obstetric Anesthesia and Postpartum Depression

产科麻醉与产后抑郁症

基本信息

项目摘要

The broad, long-term objective of the proposed project is to improve maternal health outcomes by providing access to quality obstetric anesthesia care during delivery hospitalization. Postpartum depression is a serious maternal health problem in the United States, affecting one in seven parturient, especially racial and ethnic minority women. Severe postpartum pain is associated with an increased risk of postpartum depression. Pain intensity and the risk of postpartum depression could be reduced through the use of neuraxial analgesia for vaginal delivery (i.e., epidural or spinal analgesia) or neuraxial anesthesia for cesarean delivery. Neuraxial analgesic or anesthetic techniques are the most effective evidence-based interventions to relieve postpartum pain but are underutilized in racial and ethnic minority women. Results of previous research are inconsistent on the association between the use of neuraxial analgesia or anesthesia for childbirth and the risk of postpartum depression. Inconsistency of previous research might be due to the non-consideration of newly identified strong risk factors for postpartum depression, when estimating the risk of postpartum depression. Indeed, serious maternal complications during delivery hospitalizations (i.e., severe maternal morbidity) and severe neonatal complications (e.g., preterm birth, stillbirth) have been recently linked to a significantly increased risk of PPD. The hypothesized decreased risk of postpartum depression associated with neuraxial analgesia or anesthesia for childbirth could be modified when severe maternal or neonatal complications occur. To untangle the interrelationships among neuraxial analgesia or anesthesia, maternal or neonatal complications, and postpartum depression, we will analyze data from inpatient, outpatient, and emergency department discharge records in New York State from 2006 to 2018 provided by the Healthcare Cost and Utilization Project (HCUP) of the Agency for Healthcare Research and Quality. We will use sophisticated statistical and epidemiologic methods, including causal inference techniques such as interaction and mediation analysis, and stratify our analyses according to race and ethnicity. The proposed project could provide scientific evidence for improving access to obstetric anesthesia care, especially for racial and ethnic minority women, to reduce the risk of postpartum depression and disparities in maternal mental health outcomes.
拟议项目的广泛、长期目标是通过以下方式改善孕产妇健康结果: 在分娩住院期间提供优质产科麻醉护理。 产后抑郁症在美国是一个严重的孕产妇健康问题,影响着一 七、产妇,尤其是少数民族妇女。严重的产后疼痛与 产后抑郁症的风险增加。疼痛强度和产后抑郁症的风险可能是 通过使用椎管内分娩镇痛(即硬膜外镇痛或脊髓镇痛)来减少或 剖宫产时椎管内麻醉。椎管内镇痛或麻醉技术是最有效的 以证据为基础的干预措施可缓解产后疼痛,但在少数种族和族裔中并未得到充分利用 女性。先前的研究结果对于椎管内使用之间的关联性并不一致。 分娩镇痛或麻醉以及产后抑郁症的风险。与之前的不一致 研究可能是由于没有考虑新发现的产后强风险因素 抑郁症,在估计产后抑郁症的风险时。事实上,严重的孕产妇并发症 分娩住院(即严重的产妇发病率)和严重的新生儿并发症(例如早产) 最近已发现与产后抑郁症风险显着增加有关。假设减少 与椎管内镇痛或分娩麻醉相关的产后抑郁症的风险可能是 当发生严重的孕产妇或新生儿并发症时进行修改。 理清孕产妇或新生儿椎管内镇痛或麻醉之间的相互关系 并发症和产后抑郁症,我们将分析住院、门诊和急诊的数据 纽约州 2006 年至 2018 年各部门出院记录由医疗保健费用和 医疗保健研究和质量局的利用项目 (HCUP)。我们将使用先进的 统计和流行病学方法,包括因果推理技术,例如相互作用和调解 分析,并根据种族和民族对我们的分析进行分层。 拟议的项目可以为改善产科麻醉的可及性提供科学证据 护理,特别是针对少数族裔妇女,以减少产后抑郁症和 孕产妇心理健康结果的差异。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Jean R Guglielminotti其他文献

People, We Have a Problem: Comment.
人们,我们有一个问题:评论。
  • DOI:
    10.1097/aln.0000000000004645
  • 发表时间:
    2023-08-08
  • 期刊:
  • 影响因子:
    8.8
  • 作者:
    Allison J. Lee;P. Toledo;A. Deyrup;J. Graves;D. Njoku;Jean R Guglielminotti
  • 通讯作者:
    Jean R Guglielminotti

Jean R Guglielminotti的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Jean R Guglielminotti', 18)}}的其他基金

Reducing Racial and Ethnic Disparities in Maternal Health through Policy Interventions
通过政策干预减少孕产妇健康方面的种族和民族差异
  • 批准号:
    10635586
  • 财政年份:
    2023
  • 资助金额:
    $ 20.54万
  • 项目类别:
Obstetric Anesthesia and Postpartum Depression
产科麻醉与产后抑郁症
  • 批准号:
    10642664
  • 财政年份:
    2022
  • 资助金额:
    $ 20.54万
  • 项目类别:
Medicaid Expansion and Maternal Health in Racial and Ethnic Minority Women
少数族裔妇女的医疗补助扩展和孕产妇健康
  • 批准号:
    10283253
  • 财政年份:
    2021
  • 资助金额:
    $ 20.54万
  • 项目类别:
Medicaid Expansion and Maternal Health in Racial and Ethnic Minority Women
少数族裔妇女的医疗补助扩展和孕产妇健康
  • 批准号:
    10495195
  • 财政年份:
    2021
  • 资助金额:
    $ 20.54万
  • 项目类别:

相似海外基金

Obstetric Anesthesia and Postpartum Depression
产科麻醉与产后抑郁症
  • 批准号:
    10642664
  • 财政年份:
    2022
  • 资助金额:
    $ 20.54万
  • 项目类别:
2/2: Sickle Cell Disease Treatment with Arginine Therapy (STArT) trial
2/2:精氨酸疗法治疗镰状细胞病 (START) 试验
  • 批准号:
    10488190
  • 财政年份:
    2020
  • 资助金额:
    $ 20.54万
  • 项目类别:
1/2 Sickel Cell Disease Treatment with Arginine Therapy (STArT Trial)
1/2 镰状细胞病用精氨酸疗法治疗(START 试验)
  • 批准号:
    10681276
  • 财政年份:
    2020
  • 资助金额:
    $ 20.54万
  • 项目类别:
1/2 Sickel Cell Disease Treatment with Arginine Therapy (STArT Trial)
1/2 镰状细胞病用精氨酸疗法治疗(START 试验)
  • 批准号:
    10681276
  • 财政年份:
    2020
  • 资助金额:
    $ 20.54万
  • 项目类别:
2/2: Sickle Cell Disease Treatment with Arginine Therapy (STArT) trial
2/2:精氨酸疗法治疗镰状细胞病 (START) 试验
  • 批准号:
    10681380
  • 财政年份:
    2020
  • 资助金额:
    $ 20.54万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了